Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2440135
Max Phase: Preclinical
Molecular Formula: C61H92N2O18
Molecular Weight: 1141.40
Molecule Type: Unknown
Associated Items:
ID: ALA2440135
Max Phase: Preclinical
Molecular Formula: C61H92N2O18
Molecular Weight: 1141.40
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O[C@@H]3O[C@H](C)[C@@H](OCc4ccccc4)[C@H](N(C)C)[C@H]3OC(=O)c3ccccc3)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2OC(=O)O[C@@]21C
Standard InChI: InChI=1S/C61H92N2O18/c1-18-43-61(11)52(80-58(68)81-61)35(4)46(64)33(2)30-59(9,69-16)51(78-56-47(65)42(62(12)13)29-34(3)72-56)36(5)48(37(6)54(66)75-43)76-44-31-60(10,70-17)53(39(8)73-44)79-57-50(77-55(67)41-27-23-20-24-28-41)45(63(14)15)49(38(7)74-57)71-32-40-25-21-19-22-26-40/h19-28,33-39,42-45,47-53,56-57,65H,18,29-32H2,1-17H3/t33-,34-,35+,36+,37-,38-,39+,42+,43-,44+,45+,47-,48+,49-,50-,51-,52-,53+,56+,57+,59+,60-,61-/m1/s1
Standard InChI Key: PMYMGTUYKMQUMZ-YRJUVBHASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1141.40 | Molecular Weight (Monoisotopic): 1140.6345 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zhu D, Xu Y, Liu Y, Chen X, Zhao Z, Lei P.. (2013) Synthesis of 4″-O-desosaminyl clarithromycin derivatives and their anti-bacterial activities., 23 (23): [PMID:24139585] [10.1016/j.bmcl.2013.09.083] |
Source(1):